A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

A major problem in the treatment of addiction is relapse, which is often caused by the powerful and long-lasting memories of the drug experience. Drugs of abuse can hijack or impair specific synaptic ...

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud ...